Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Tremblay

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Hematology. American Society of Hematology. Education Program|December 9, 2023
Cytoreduction for ET and PV: who, what, when, and how?Douglas Tremblay
Current Treatment Options in Oncology|January 14, 2023
New Treatments for MyelofibrosisDouglas Tremblay, Ruben Mesa
Expert Review of Hematology|July 13, 2018
Pacritinib to treat myelofibrosis patients with thrombocytopeniaDouglas Tremblay, John Mascarenhas
Expert Opinion on Emerging Drugs|December 7, 2021
Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trialsDouglas Tremblay, Ronald Hoffman
Expert Opinion on Pharmacotherapy|October 27, 2025
Pharmacologic management of ET: established therapies and emerging agentsRejowana Rouf, Douglas Tremblay
Future Oncology (London, England)|May 23, 2022
Momelotinib for the treatment of myelofibrosis with anemiaDouglas Tremblay, Ruben Mesa
Expert Opinion on Pharmacotherapy|March 16, 2023
Pharmacotherapeutic advances for splenomegaly in myelofibrosisDouglas Tremblay, John Mascarenhas
International Journal of Hematology|February 19, 2022
Novel treatments for myelofibrosis: beyond JAK inhibitorsDouglas Tremblay, Ruben Mesa
Therapeutics and Clinical Risk Management|July 5, 2023
Emerging Treatment Options for Myelofibrosis: Focus on AnemiaDahniel Sastow, Douglas Tremblay
Current Hematologic Malignancy Reports|February 9, 2020
Novel Therapies in Polycythemia VeraDouglas Tremblay, John Mascarenhas
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Hematology. American Society of Hematology. Education Program|December 9, 2023
Cytoreduction for ET and PV: who, what, when, and how?Douglas Tremblay
Current Treatment Options in Oncology|January 14, 2023
New Treatments for MyelofibrosisDouglas Tremblay, Ruben Mesa
Expert Review of Hematology|July 13, 2018
Pacritinib to treat myelofibrosis patients with thrombocytopeniaDouglas Tremblay, John Mascarenhas
Expert Opinion on Emerging Drugs|December 7, 2021
Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trialsDouglas Tremblay, Ronald Hoffman
Expert Opinion on Pharmacotherapy|October 27, 2025
Pharmacologic management of ET: established therapies and emerging agentsRejowana Rouf, Douglas Tremblay
Future Oncology (London, England)|May 23, 2022
Momelotinib for the treatment of myelofibrosis with anemiaDouglas Tremblay, Ruben Mesa
Expert Opinion on Pharmacotherapy|March 16, 2023
Pharmacotherapeutic advances for splenomegaly in myelofibrosisDouglas Tremblay, John Mascarenhas
International Journal of Hematology|February 19, 2022
Novel treatments for myelofibrosis: beyond JAK inhibitorsDouglas Tremblay, Ruben Mesa
Therapeutics and Clinical Risk Management|July 5, 2023
Emerging Treatment Options for Myelofibrosis: Focus on AnemiaDahniel Sastow, Douglas Tremblay
Current Hematologic Malignancy Reports|February 9, 2020
Novel Therapies in Polycythemia VeraDouglas Tremblay, John Mascarenhas
Pageof 11